Federation des caisses Desjardins du Quebec
BCYC icon

Federation des caisses Desjardins du Quebec’s Bicycle Therapeutics BCYC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Hold
14,302
– – ﹤0.01% 1878
2026
Q1 		$66.5K Hold
14,302
– – ﹤0.01% 1788
2025
Q4 		$101K Hold
14,302
– – ﹤0.01% 1665
2025
Q3 		$111K Buy
14,302
+4,699
+49% +$35.5K ﹤0.01% 1609
2025
Q2 		$66.8K Buy
9,603
+9,542
+15,643% +$76K ﹤0.01% 1475
2025
Q1 		$518 Hold
61
– – ﹤0.01% 2483
2024
Q4 		$854 Hold
61
– – ﹤0.01% 2336
2024
Q3 		$1.38K Hold
61
– – ﹤0.01% 2284
2024
Q2 		$1.24K Buy
+61
New +$1.38K ﹤0.01% 2166

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BCYC Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 14,302 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Federation des caisses Desjardins du Quebec first reported a position in BCYC in Q2 2024 and has held it in 9 quarters since. The position peaked at $111K in Q3 2025. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 14,302 shares of Bicycle Therapeutics worth $60.6K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1878 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Federation des caisses Desjardins du Quebec's Bicycle Therapeutics position peaked at $111K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.